ACTC1 Gene – Familial Hypertrophic Cardiomyopathy Type 11 (Genetic Test) in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين ACTC1 لاعتلال عضلة القلب الضخامي العائلي النوع 11 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

الملخص التنفيذي

دقة تشخيصية 99.9% عبر مختبر معتمد ISO. خدمة سحب منزلي فاخر بسلسلة تبريد ذكية. إرشاد سريري هاتفي بعد النتائج. التحقق المباشر من تغطية التأمين عبر واتساب: +971 54 548 8731.

Test Overview

This Next-Generation Sequencing (NGS) test analyzes the entire coding region of the ACTC1 gene for pathogenic variants linked to Familial Hypertrophic Cardiomyopathy Type 11, enabling definitive genetic diagnosis for affected individuals and cascade screening of at-risk family members.

Feature	Our ACTC1 NGS Test	Closest Alternative (Single-Gene PCR)
Precision	99.9% Diagnostic Sensitivity via full gene coverage and ISO-accredited NGS	Limited to known hotspot mutations; higher false‑negative risk
Methodology	Next-Generation Sequencing (ISO 9001:2015 certified)	Sanger sequencing or targeted PCR
Turnaround Time	3–4 Weeks (comprehensive analysis with expert interpretation)	6–8 weeks (fragmented, manual workflows)

Physician Insight & Safety Protocol

“Genetic testing for ACTC1 provides critical insights, but it must be correlated with clinical and family history. A negative result does not eliminate risk, particularly in families with a strong clinical picture. Always interpret findings in the context of a comprehensive cardiogenetic evaluation.”

— Dr. Prabhakar Reddy, DHA License 61713011, Consultant Cardiologist

Do not discontinue prescribed medication without consulting your doctor.

Safety & Exclusion Criteria

Pre‑test genetic counselling is mandatory; patients who cannot attend a counselling session may not qualify for insurance coverage.
Blood draw is contraindicated in the presence of severe coagulopathy or active infection at the venipuncture site.
Emergency Red Flags: Sudden cardiac arrest, unexplained syncope, or severe chest pain require immediate emergency care—do not wait for test results.

Frequently Asked Questions

What is the accuracy of this test for detecting ACTC1 mutations?

This NGS-based test delivers 99.9% analytical sensitivity for all coding regions and splice junctions of ACTC1, ensuring no common mutation is missed.

How long does it take to receive results and what support is provided?

Results are available within 3 to 4 weeks, accompanied by a post‑test telephonic clinical guidance session to interpret findings for you and your family.

Is this covered by UAE health insurance?

Direct billing verification is available via WhatsApp at +971 54 548 8731; many UAE policies cover genetic testing for cardiomyopathy when medically indicated.

هل يتطلب هذا الفحص استشارة وراثية مسبقة؟

نعم، يجب إجراء جلسة استشارة وراثية لرسم شجرة العائلة وتوثيق التاريخ الطبي قبل سحب العينة.

Compliant with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL. Licensed Facility No. 9834453. ISO 9001:2015 Certified (INT/EGQ/2509DA/3139).

دعم ثنائي اللغة متاح